Table 2.
Antibiotic susceptibility patterns ofV. fluvialisstrains
|
Antibiotic |
Breakpoints (mg/ml) |
Resistance |
Sensitivity |
|
|---|---|---|---|---|
| R (%) | I (%) | S (%) | ||
| Ampicillin |
S<=8 I=16 R>=32a |
12 (27.3) |
8 (18.2) |
24 (54.5) |
| Amoxicillin/Clavulanic acid |
S<=8/4 I=16/8 R>=32/16b |
10 (22.7) |
7 (15.9) |
27 (61.4) |
| Cefotaxime |
S<=1 I=2 R>=4b |
1 (2.3) |
6 (13.6) |
37 (84.1) |
| Ceftriaxone |
S<=1 I=2 R>=4b |
1 (2.3) |
6 (13.6) |
37 (84.1) |
| Ceftazidime |
S<=4 I=8 R>=16b |
0 (0) |
0 (0) |
44 (100) |
| Chloramphenicol |
S<=8 I=16 R>=32a |
0 (0) |
0 (0) |
44 (100) |
| Ciprofloxacin |
S<=1 I=2 R>=4b |
0 (0) |
0 (0) |
44 (100) |
| Gentamicin |
S<=4 I=8 R>=16b |
0 (0) |
0 (0) |
44 (100) |
| Nalidixic acid |
S<=16 R>=32b |
0 (0) |
- |
44 (100) |
| Streptomycin |
S<16 R>=16d |
1 (2.3) |
- |
43 (97.7) |
| Sulfamethoxazole |
S<=256 R>=512a |
11 (25.0) |
- |
33 (75.0) |
| Trimethoprim |
S<=8 R>=16b |
0 (0) |
- |
44 (100) |
| Co-trimoxazole |
S<=2/38 R>=4/76a |
0 (0) |
- |
44 (100) |
| Tetracycline |
S<=4 I=8 R>=16a |
1 (2.3) |
0 (0) |
43 (97.7) |
| Azithromycin | S<=2 I=4 R>=8c | 12 (27.3) | 5 (11.4) | 27 (61.3) |
aBreakpoints are based on the CLSI standards for V. cholerae.
bBreakpoints refer to the CLSI criteria for Enterobacteriaceae.
cBreakpoint is based on the CLSI standards for C. jejuni.
dBreakpoint refer to the reference [61].
R, resistance; I, intermediate; S, sensitivity.